Differential effects of anxiolytics and beta-receptor blocking drugs on novelty-oriented ("neophobic") behavior in the rat

Pharmacopsychiatry. 1988 Jul;21(4):186-91. doi: 10.1055/s-2007-1014673.

Abstract

The effects of diazepam, I-propranolol and isamoltane (CGP 361 A) (I-isopropylamino-3[2-(I-pyrrolyl)-phenoxy]-2-propranol), a drug with beta-receptor blocking and anxiolytic-like properties, on behavioral responses in rats encountering either a novel object or a drinking bottle in an unfamiliar open-field ("neophobic" behavior) were evaluated. Diazepam (1-5 mg/kg p.o.) and isamoltane (0.5-1.0 mg/kg p.o.) showed a similar pattern of effects in both test paradigms used. They counteracted the fear-induced suppression of behavioral responses in the presence of novelty: they shortened the approach latencies, increased the exploration-oriented activities and reduced grooming. Propranolol, however, in comparison with isamoltane (1.0 and 2.5 mg/kg i.p.) at equivalent doses, failed to significantly change any of the parameters measured in either of the two test situations. The results therefore indicate that neophobic behavioral responses discriminate between central anxiolytic and peripheral beta-blocking actions of drugs and further validate neophobic behavior as an animal model of anxiety.

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology*
  • Animals
  • Anti-Anxiety Agents / pharmacology*
  • Anxiety / psychology*
  • Behavior, Animal / drug effects*
  • Diazepam / pharmacology
  • Drinking Behavior / drug effects
  • Exploratory Behavior / drug effects
  • Male
  • Motor Activity / drug effects
  • Organic Chemicals
  • Propranolol / pharmacology
  • Rats
  • Rats, Inbred Strains

Substances

  • Adrenergic beta-Antagonists
  • Anti-Anxiety Agents
  • CGP 361
  • Organic Chemicals
  • Propranolol
  • Diazepam